Exscientia presents three posters demonstrating potential of precision medicine platform in drug discovery at the american association of cancer research annual meeting 2022

Oxford, england & vienna, austria--(business wire)--exscientia plc (nasdaq: exai) today shared details of its participation at the upcoming american association for cancer research (aacr) annual meeting, taking place april 8-13 2022 at the ernest n. morial convention center in new orleans, la. exscientia scientists will present new research in three poster presentations. “we are looking forward to meeting with some of the world's leading cancer clinicians and researchers at this year's aacr mee
EXAI Ratings Summary
EXAI Quant Ranking